Loading...
XHKG
0570
Market cap1.48bUSD
Jul 14, Last price  
2.31HKD
1D
1.76%
1Q
17.86%
Jan 2017
-35.65%
Name

China Traditional Chinese Medicine Holdings Co Ltd

Chart & Performance

D1W1MN
P/E
196.42
P/S
0.64
EPS
0.01
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
2.89%
Revenues
16.51b
-8.90%
857,770,860109,923,041333,387,006390,532,784590,055,111800,390,967822,224,8441,021,100,2221,394,613,0002,690,173,0003,709,406,0006,532,867,0008,337,795,00011,258,941,00014,320,949,00014,806,168,00019,052,802,00014,304,242,00018,121,861,00016,509,707,999
Net income
54m
-95.79%
0023,452,69117,900,65538,787,31351,921,80758,329,902166,782,904198,463,000413,090,000621,692,000966,927,0001,170,434,0001,439,018,0001,588,114,0001,663,255,0001,932,858,000764,486,0001,285,200,00054,067,000
CFO
0k
-100.00%
70,928,34145,271,92548,352,73261,346,506150,697,70261,893,6920183,648,48384,859,000324,999,000518,701,0001,464,640,0001,235,594,0001,190,491,0001,585,094,000228,474,000796,029,0001,092,362,0001,168,809,0000
Dividend
Jun 23, 20250.0865 HKD/sh

Profile

China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company offers granules, finished drugs, decoction pieces, and healthcare products. It is also involved in the plantation and management of Chinese medicinal herbs; manufacturing of traditional Chinese medicines (TCM); trading of pharmaceutical products; provision of TCM marketing, advertising, and consulting services; and retail of pharmaceuticals and decoction products. The company also provides property leasing services. It sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in July 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited was founded in 1573 and is headquartered in Wan Chai, Hong Kong.
IPO date
Apr 07, 1993
Employees
17,373
Domiciled in
HK
Incorporated in
HK

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
16,509,708
-8.90%
18,121,861
26.69%
14,304,242
-24.92%
Cost of revenue
15,726,342
16,979,520
13,266,123
Unusual Expense (Income)
NOPBT
783,366
1,142,341
1,038,119
NOPBT Margin
4.74%
6.30%
7.26%
Operating Taxes
142,338
(171,537)
119,357
Tax Rate
18.17%
11.50%
NOPAT
641,028
1,313,878
918,762
Net income
54,067
-95.79%
1,285,200
68.11%
764,486
-60.45%
Dividends
(240,000)
(314,427)
Dividend yield
1.21%
1.76%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,123,916
2,969,340
4,513,642
Long-term debt
1,989,359
2,289,256
608,568
Deferred revenue
421,291
437,839
Other long-term liabilities
1,438,764
Net debt
(1,233,795)
1,556,135
2,041,803
Cash flow
Cash from operating activities
1,168,809
1,092,362
CAPEX
(483,925)
(527,273)
Cash from investing activities
(477,620)
(374,153)
Cash from financing activities
(584,306)
(557,279)
FCF
3,077,510
137,366
(256,263)
Balance
Cash
5,336,149
3,690,614
3,670,176
Long term investments
10,921
11,847
(589,769)
Excess cash
4,521,585
2,796,368
2,365,195
Stockholders' equity
23,933,034
23,936,618
23,175,497
Invested Capital
24,865,851
26,721,675
25,677,109
ROIC
2.49%
5.01%
3.56%
ROCE
2.67%
3.72%
3.50%
EV
Common stock shares outstanding
5,035,802
5,035,801
5,035,801
Price
2.31
-41.22%
3.93
10.70%
3.55
-31.33%
Market cap
11,632,702
-41.22%
19,790,698
10.70%
17,877,094
-31.33%
EV
13,128,157
24,123,316
22,927,674
EBITDA
783,366
2,275,612
2,137,516
EV/EBITDA
16.76
10.60
10.73
Interest
199,045
220,695
Interest/NOPBT
17.42%
21.26%